Drug Approval | January 03, 2024
Alembic Pharmaceuticals received 8 USFDA approvals in Q3FY24
The company has received five final approvals
The company has received five final approvals
Roche will pay a purchase price of USD 295 million and an additional payment of up to USD 55 million
XTANDI becomes the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy in nonmetastatic castration-sensitive prostate cancer
Lack of technology transfer stands out as a formidable barrier
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Need to harmonize traditional and modern medicine to combat alarming health problems
The National Dental Commission Act 2023, will introduce a groundbreaking regulatory framework by establishing the National Dental Commission
Several crucial provisions to elevate the standards of nursing education and services, enhance professional conduct, and ensure greater transparency and accountability introduced
Luforbec® 100/6 pMDI aims to provide comprehensive support to patients and healthcare professionals
Subscribe To Our Newsletter & Stay Updated
